Calypso Biotech is the third spin-off company from the EPP Fund. The company is developing an anti IL-15 antibody against immune disorders, currently evaluated in celiac disease and eosinophilic esophagitis. Calypso Biotech is based in Geneva, Switzerland and Amsterdam, Netherlands.
Location: Netherlands, North Holland, Amsterdam
Total raised: $55.8M
Investors 2
| Date | Name | Website |
| 21.02.2023 | M Ventures | m-ventures... |
| - | Gilde Heal... | gildehealt... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 09.09.2021 | - | $33.1M | - |
| 21.02.2019 | Series A | $22.69M | Gilde Heal... |
Mentions in press and media 13
| Date | Title | Description | Source |
| 08.01.2024 | Calypso Enters into Agreement to Be Acquired by Novartis | Calypso is a European biotech translating Interleukin-15 biology into medical breakthroughs by devel... | fh-partner... |
| 20.09.2021 | Clinical progression and €8M funding for Calypso Biotech | Calypso Biotech’s lead program, CALY-002, is a best-in-class therapeutic antibody that binds to and ... | startuptic... |
| 09.09.2021 | Calypso Biotech Announces First Patient With Celiac Disease ... | - | jnjinnovat... |
| 09.09.2021 | Calypso Biotech announces first patient with Celiac Diseas... | Calypso Biotech, a leader in the development of Interleukin-15 (IL-15) targeted therapies, announc... | fh-partner... |
| 26.02.2019 | String of successes for Merck Serono spin-offs | Calypso Biotech, an emerging leader in the development of therapeutic antibodies for autoimmune di... | startuptic... |
| 21.02.2019 | Gilde Healthcare leads EUR 20M Series A financing round of C... | Utrecht, The Netherlands and Boston, US - Calypso Biotech (Amsterdam, The Netherlands), an emerging ... | gildehealt... |
| 21.02.2019 | Term Sheet — Thursday, February 21 | LYFT PREDICTIONS Good morning, Term Sheet readers. Paid Content Securing the enterprise without bo... | fortune.co... |
| 20.02.2019 | Calypso Biotech Secures €20M in Series A Financing | Calypso Biotech, an Amsterdam, the Netherlands-based developer of therapeutic antibodies for autoimm... | finsmes.co... |
| 20.02.2019 | Daily funding roundup - February 20th, 2019 | ThinkGenetic has raised $1.5M; Staytuned raised $2.5M; Senseon raised $6.4M; ParkHub raised $13M Th... | vator.tv/n... |
| 20.02.2019 | Calypso Biotech BV Secures 20 Million EUR in Series A Financ... | - | jnjinnovat... |
Show more